Idaho Kept Out of Washington’s Suit Over Abortion-Inducing Pill

Idaho may not join Washington’s lawsuit challenging the US Food and Drug Administration’s regulations on mifepristone, a drug used to induce abortions during the earliest stage of pregnancy, the Ninth Circuit said Wednesday.

Washington sued FDA, arguing that the agency should do away with its risk mitigation and evaluation strategy for the drug because mifepristone hasn’t been shown to present the dangers that prompted the agency to heighten regulations. FDA’s 2023 rollback of some of those rules—in particular its elimination of an in-person dispensing requirement and addition of a provision allowing some retail pharmacies to sell the drug—didn’t go far ...